AS-924, a Novel Bifunctional Prodrug of Ceftizoxime
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-05-25
著者
-
Kasai Masayasu
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd.
-
Shirahase Hiroaki
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd.
-
Kanda Mamoru
Research Laboratories Kyoto Pharmaceutical Industries Ltd.
-
Shirahase Hiroaki
Research Laboratories Kyoto Pharmaceutical Industries Ltd.
-
Shirahase Hiroaki
Research Laboratories Kyoto Pharmaceutical Company Ltd.
-
Nishimura Ken-ichi
Research Laboratories Kyoto Pharmaceutical Industries Ltd.
-
YOSHIMI Akihisa
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd.
-
Kakeya Nobuharu
Research Laboratories Kyoto Pharmaceutical Industries Ltd.
-
Kanda M
Research Laboratories Kyoto Pharmaceutical Industries Ltd.
-
Yoshimi A
Research Laboratories Kyoto Pharmaceutical Industries Ltd.
-
Shirahase H
Research Laboratories Kyoto Pharmaceutical Industries Ltd.
-
HATANO Satoru
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd.,
-
KITAGAWA Meiko
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd.,
-
NISHIMURA Ken-
Research Laboratories, Kyoto Pharmaceutical Industries, Ltd.
-
Hatano Satoru
Research Laboratories Kyoto Pharmaceutical Industries Ltd.
-
Yoshimi Akihisa
Research Laboratories Kyoto Pharmaceutical Industries Ltd.
-
Kakeya Nobuharu
Research Laboratories Kyoto Pharmaceutical Industries
-
Kasai Masayasu
Research Laboratories, Kyoto Pharmaceutical Industries
関連論文
- Novel Tetrahydroisoquinoline Derivatives with Inhibitory Activities against Acyl-CoA: Cholesterol Acyltransferase and Lipid Peroxidation
- Novel Acyl-CoA: Cholesterol Acyltransferase Inhibitor: Indoline-Based Sulfamide Derivatives with Low Lipophilicity and Protein Binding Ratio
- A Novel Series of Thromboxane A_2 Synthetase Inhibitors with Free Radical Scavenging and Anti-peroxidative Activities
- Bioavailable Acyl-CoA : Cholesterol Acyltransferase Inhibitor with Anti-peroxidative Activity : Synthesis and Biological Activity of Novel Indolinyl Amide and Urea Derivatives
- Inhibitory Effect of Acyl-CoA : Cholesterol Acyltransferase Inhibitor-Low Density Lipoprotein Complex on Experimental Atherosclerosis(Biopharmacy)
- Synthesis and Biological Evaluation of (S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acids : A Novel Series of PPARγ Agonists
- AS-924,a Novel Orally Active Bifunctional Prodrug of Ceftizoxime. Synthesis and Relationship between Physicochemical Properties and Oral Absorption
- AS-924, a Novel Bifunctional Prodrug of Ceftizoxime
- Characteristics of 1,3-Bis-(2-ethoxycarbonylchromon-5-yloxy)-2-((S)-lysyloxy) propane Dihydrochloride (N-556), a Prodrug for the Oral Delivery of Disodium Cromoglycate, in Absorption and Excretion in Rats and Rabbits
- PRODRUGS FOR THE ORAL DELIVERY OF DISODIUM CROMOGLYCATE (DSCG)
- STRUCTURE-ORAL ABSORPTION RELATIONSHIP OF NEW ORALLY ACTIVE CEPHALOSPORIN ESTERS, CEFCANEL DALOXATE AND THE RELATED COMPOUNDS
- Effects of Cholesterol Diet on Vasculopathy and Nephropathy in Salt-loaded Dahl-S Rats(Circulatory system, Proceedings of the 32nd Annual Meeting)
- Effect of Topically Applied Iganidipine Dihydrochloride, a Novel Calcium Antagonist, on Optic Nerve Head Circulation in Rabbits
- 2-Acyl-tetrahydroisoquinoline-3-carboxylic Acids: Lead Compounds with Triple Actions, Peroxisome Proliferator-Activated Receptor α/γ Agonist and Protein-Tyrosine Phosphatase 1B Inhibitory Activities
- A Novel Series of (S)-2,7-Substituted-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acids: Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists with Protein-Tyrosine Phosphatase 1B Inhibitory Activity
- Importance of Hydrolysis of Amino Acid Moiety in Water-Soluble Prodrugs of Disodium Cromoglycate for Increased Oral Bioavailability
- Novel prodrugs of meropenem with two lipophilic promoieties : synthesis and pharmacokinetics
- Inhibitory effects of trimetazidine dihydrochloride on aggregation, serotonin release and malondialdehyde production in rabbit platelets.
- Effect of Indapamide on the Proliferation of Balb/C 3T3 Cells Induced by Platelet-Derived Growth Factor.